Closing arguments in LabMD case revolve around whether FTC met its burden
The following article first appeared on Sept. 17 on MLex. For more information on MLex, including getting access to its exclusive content, please contact sales@mlex.com....To view the full article, register now.
Already a subscriber? Click here to view full article